Latest News by Industry
SEATTLE (AP) — SEATTLE (AP) — Adaptive Biotechnologies Corp. (ADPT) on Tuesday reported a loss of $40.1 million in its fourth quarter.
The Seattle-based company said it had a loss of 28 cents per share.
The results topped Wall Street expectations. The average estimate of four analysts surveyed by Zacks Investment Research was for a loss of 37 cents per share.
The life-sciences research company posted revenue of $55.2 million in the period, which fell short of Street forecasts. Five analysts surveyed by Zacks expected $55.9 million.
For the year, the company reported that its loss narrowed to $200.2 million, or $1.40 per share. Revenue was reported as $185.3 million.
Adaptive Biotechnologies expects full-year revenue in the range of $205 million to $215 million.
Adaptive Biotechnologies shares have risen 14% since the beginning of the year. In the final minutes of trading on Tuesday, shares hit $8.68, a decline of 41% in the last 12 months.
_____
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a ADPT">Zacks stock report on ADPT at https://www.zacks.com/ap/ADPT